Hoberman Alan M's Form 4 filing
Bioxytran, Inc (BIXT) · filed Nov 18, 2025
- Accession no.
- 0001445815-25-000011
- Filed
- Nov 18, 2025, 4:15 PM ET
- Trade date
- Aug 12-Nov 18, 2025
- Filing delay
- 98 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $126.0K. It was filed 98 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoberman Alan MCIK 0001636357 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | preferred | AGrant or awardAcquired | +10,417 | $0.485 | +$5,052.25 | 377,619 | Direct | |
| Nov 14, 2025 | preferred | AGrant or awardAcquired | +38,588 | $0.35 | +$13,505.8 | 416,207 | Direct | |
| Nov 18, 2025 | common | PPurchaseAcquired | +210,000 | $0.60 | +$126,000 | 210,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.